Reuters logo
BRIEF-Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara
2017年5月18日 / 下午1点13分 / 5 个月内

BRIEF-Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara

May 18 (Reuters) - Biogen Inc

* Biogen acquires Remedy Pharmaceuticals’ late-stage drug cirara

* Biogen Inc says Biogen made an upfront payment of $120 million to remedy and may also pay additional milestone payments and royalties

* Says Biogen made an upfront payment of $120 million to remedy and may also pay additional milestone payments and royalties Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below